JP2010504934A5 - - Google Patents

Download PDF

Info

Publication number
JP2010504934A5
JP2010504934A5 JP2009529613A JP2009529613A JP2010504934A5 JP 2010504934 A5 JP2010504934 A5 JP 2010504934A5 JP 2009529613 A JP2009529613 A JP 2009529613A JP 2009529613 A JP2009529613 A JP 2009529613A JP 2010504934 A5 JP2010504934 A5 JP 2010504934A5
Authority
JP
Japan
Prior art keywords
cyclic
acid
pharmaceutical composition
compound
diagnostic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009529613A
Other languages
English (en)
Japanese (ja)
Other versions
JP5335677B2 (ja
JP2010504934A (ja
Filing date
Publication date
Priority claimed from EP06020286A external-priority patent/EP1905454A1/en
Application filed filed Critical
Publication of JP2010504934A publication Critical patent/JP2010504934A/ja
Publication of JP2010504934A5 publication Critical patent/JP2010504934A5/ja
Application granted granted Critical
Publication of JP5335677B2 publication Critical patent/JP5335677B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009529613A 2006-09-27 2007-09-27 環状化合物を含む製剤 Expired - Fee Related JP5335677B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06020286A EP1905454A1 (en) 2006-09-27 2006-09-27 Formulations comprising cyclic compounds
EP06020286.8 2006-09-27
PCT/EP2007/008442 WO2008037484A2 (en) 2006-09-27 2007-09-27 Formulations comprising cyclic compounds

Publications (3)

Publication Number Publication Date
JP2010504934A JP2010504934A (ja) 2010-02-18
JP2010504934A5 true JP2010504934A5 (enExample) 2010-12-09
JP5335677B2 JP5335677B2 (ja) 2013-11-06

Family

ID=37728182

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009529613A Expired - Fee Related JP5335677B2 (ja) 2006-09-27 2007-09-27 環状化合物を含む製剤

Country Status (10)

Country Link
US (1) US8513188B2 (enExample)
EP (2) EP1905454A1 (enExample)
JP (1) JP5335677B2 (enExample)
CN (2) CN101557829A (enExample)
AU (1) AU2007302270B2 (enExample)
BR (1) BRPI0714761B8 (enExample)
CA (1) CA2664568C (enExample)
ES (1) ES2691736T3 (enExample)
IL (1) IL197760A (enExample)
WO (1) WO2008037484A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2332929A1 (en) * 2009-11-25 2011-06-15 ArisGen SA Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions
CN102770152B (zh) * 2009-11-25 2016-07-06 阿瑞斯根股份有限公司 肽类的粘膜递送
EP2526971A1 (en) * 2011-05-25 2012-11-28 ArisGen SA Mucosal delivery of drugs
CN102863358B (zh) * 2012-09-20 2014-02-12 华中农业大学 具有除草活性的化合物及其制备方法
EP3000811B1 (en) * 2014-09-24 2017-11-08 Friedrich-Alexander-Universität Erlangen-Nürnberg Crown Ether Complexes and Methods for Poducing the Same
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9375478B1 (en) 2015-01-30 2016-06-28 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
CN108658264B (zh) * 2018-04-17 2021-05-25 唐山师范学院 多支化聚环氧琥珀酸衍生物阻垢缓蚀剂的制备及其应用方法
CN113527672B (zh) * 2020-03-30 2022-09-20 复旦大学 一种胍基衍生物及其基因递释系统
CN116178887B (zh) * 2023-02-16 2024-10-29 东华大学 一种可降解快递袋材料及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
US4474753A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Topical drug delivery system utilizing thermosetting gels
EP0248885B1 (en) * 1985-12-04 1992-08-05 HSIEH, Dean Transdermal delivery of drugs
US5023252A (en) * 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
ES2395096T3 (es) * 1999-06-29 2013-02-08 Mannkind Corporation Purificación y estabilización de agentes farmacéuticos a base de péptidos y proteínas
HK1047433A1 (en) * 1999-09-20 2003-02-21 Amato Pharmaceutical Products, Ltd. Process for the preparation of cyclic lactic acid oligomers
MXPA04005611A (es) * 2001-12-11 2005-04-19 Cellgate Inc Reactivos y conjugados de transporte de guanidinio.
JP2006232909A (ja) * 2005-02-23 2006-09-07 Tokai Univ 環状オリゴ乳酸

Similar Documents

Publication Publication Date Title
Gangloff et al. Peptoids and polypeptoids at the frontier of supra-and macromolecular engineering
JP5335677B2 (ja) 環状化合物を含む製剤
US6306993B1 (en) Method and composition for enhancing transport across biological membranes
Fukuzumi et al. Chemoselective cyclization of unprotected linear peptides by α-ketoacid–hydroxylamine amide-ligation
EP4249496A1 (en) Method for supporting amino acid on resin for solid-phase synthesis
CN102112485B (zh) 乙酸格拉默(glatiramer acetate)的合成
JP2024521757A5 (enExample)
US10758623B2 (en) Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
Caumes et al. Cyclic α, β-tetrapeptoids: Sequence-dependent cyclization and conformational preference
RU2003123491A (ru) Лекарственная комбинация из бигуанида и переносчика, например из метформина и аргинина
CN115403663B (zh) 一种PTP1B多肽抑制剂BimBH3-12-I8A及其应用
Furgal et al. Accessing sequence specific hybrid peptoid oligomers with varied pendant group spacing
Maity et al. Tetrahydrofuran Cα-tetrasubstituted amino acids: two consecutive β-turns in a crystalline linear tripeptide
JPH0782225A (ja) アミノ酸誘導体及びその用途
JP2008291207A (ja) 塩基性アミノ酸を有するらせん状ポリマー
Métro et al. Amino Acids and Peptides in Ball Milling
WO2023005945A1 (zh) 一种环肽及其制备方法和应用
EP3829624A1 (fr) Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline, au moins une espece ionique et un compose amphiphile porteur de radicaux hydrophobes
CN1296360C (zh) (1r,2r)-或(1s,2s)-1-(4'-取代-1',8'-萘酰亚胺基)-2-氨基环己烷及其制法和用途
CN116333086A (zh) 一种寡肽环肽及其应用
Hartwig et al. From peptides to their alternating ester-urea analogues: synthesis and influence of hydrogen bonding motif and stereochemistry on aggregation
JP2009096929A (ja) 擬似ペプチドライブラリー
JP2016166151A (ja) ペプチド化合物及びペプチド化合物の製造方法
CN120463765B (zh) 一种铁催化的无保护甘氨酸或氮端甘氨酸多肽的修饰方法
WO2007060860A1 (ja) ピロールイミダゾールポリアミドの固相自動合成